| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |